NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

NordicInfu Care

Status: Completed

Conditions: Pulmonary Hypertension Group 1 and 4 According to Nice Classification

Study type: Observational

Funder types: Industry

Identifiers

NCT01977014

NIMS/PAH/LP/001

Details and patient eligibility

About

This observational study aims to chart patients which get their prostacyclin treatment via the subcutaneous LenusPro pump. How the surgical procedure is performed and the clinical follow-up of these patients. And by this also charting complications that might occur in relation to treatment.

Participating centres are located in Denmark, Norway and Sweden.

Enrollment: 40 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient should have been diagnosed with Pulmonary Arterial Hypertension
• The patient has received or will receive treatment with the implanted pump LenusPro

Exclusion criteria

• The patient is participating in another study which means treatment of the patient no longer follows the normal clinical practice

Trial design

40 participants in 1 patient group

Patient with LenusPro pump